SAG (Smoothened Agonist) HCl

Catalog No.S7779 Batch:S777906

Print

Technical Data

Formula

C28H29Cl2N3OS
Molecular Weight 526.52 CAS No. 2095432-58-7
Solubility (25°C)* In vitro DMSO 100 mg/mL (189.92 mM)
Water 100 mg/mL (189.92 mM)
Ethanol Insoluble
In vivo (Add solvents to the product individually and in order)
Clear solution
water
100.0mg/ml Taking the 1 mL working solution as an example, add 100 mg of this product to 1 ml of ddH2O, mix evenly to make it clear, The mixed solution should be used immediately for optimal results. 
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
* Room temperature shipping (Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

Biological Activity

Description SAG (Smoothened Agonist) HCl is a cell-permeable Smoothened (Smo) agonist with EC50 of 3 nM in Shh-LIGHT2 cells.
Targets
Smoothened [1]
(mouse cultured cell assay)
3 nM(EC50)
In vitro

SAG regulates Smo activity by binding directly to the Smo heptahelical bundle. [1]

SAG induces Smo-dependent signaling through Gli in a GRK2-dependent way. [2]

SAG also (1 nM) induces proliferation of neuronal and glial precursors without affecting the differentiation pattern of newly produced cells. [3]
In vivo

In the adult rat hippocampus, the intracerebroventricular administration of SAG (2.5 nM) significantly increases the number of newly generated cells and extends survival of hippocampal cells. [3]

In mice, SAG (20 μg/g, i.p.) effectively prevents GC-induced neonatal cerebellar developmental abnormalities. [4]

Protocol (from reference)

Kinase Assay:

[1]
  • Cell-Based Assays for Hh Pathway Activation

    Assays for Hh pathway activation in Shh-LIGHT2 cells, a clonal NIH 3T3 cell line stably incorporating Gli-dependent firefly luciferase and constitutive Renilla luciferase reporters, are conducted. For studies of SAG (a chlorobenzothiophene-containing Hh pathway agonist) and PA-SAG, Shh-LIGHT2 cells are cultured to confluency in 96-well plates and then treated with various concentrations of these compounds in DMEM containing 0.5% (vol/vol) bovine calf serum.
Cell Assay:

[1]
  • Cell lines

    Shh-LIGHT2 cells

  • Concentrations

    3 nM

  • Incubation Time

    30 h

  • Method

    Cells were treated with various concentrations of SAG in DMEM containing 0.5% (vol/vol) bovine calf serum.
Animal Study:

[3]
  • Animal Models

    Rat

  • Dosages

    2.5 nM

  • Administration

    Intracerebroventricular administration

Customer Product Validation

Data from [Data independently produced by , , J Pain Res, 2018, 11:649-659]

Selleck's SAG (Smoothened Agonist) HCl has been cited by 73 publications

Jag1/2 maintain esophageal homeostasis and suppress foregut tumorigenesis by restricting the basal progenitor cell pool [ Nat Commun, 2024, 15(1):4124] PubMed: 38750026
Jag1/2 maintain esophageal homeostasis and suppress foregut tumorigenesis by restricting the basal progenitor cell pool [ Nat Commun, 2024, 15(1):4124] PubMed: 38750026
An epilepsy-associated CILK1 variant compromises KATNIP regulation and impairs primary cilia and Hedgehog signaling [ bioRxiv, 2024, 2024.05.14.594243] PubMed: 38798407
Spatially controlled construction of assembloids using bioprinting [ Nat Commun, 2023, 14(1):4346] PubMed: 37468483
Spatially controlled construction of assembloids using bioprinting [ Nat Commun, 2023, 14(1):4346] PubMed: 37468483
Highly reproducible and cost-effective one-pot organoid differentiation using a novel platform based on PF-127 triggered spheroid assembly [ Biofabrication, 2023, 15(4).] PubMed: 37552975
Selective induction of human renal interstitial progenitor-like cell lineages from iPSCs reveals development of mesangial and EPO-producing cells [ Cell Rep, 2023, S2211-1247(23)01614-5] PubMed: 38237600
Heat promotes melanogenesis by increasing the paracrine effects in keratinocytes via the TRPV3/Ca2+/Hh signaling pathway [ iScience, 2023, 26(5):106749] PubMed: 37216091
Acquisition of neural fate by combination of BMP blockade and chromatin modification [ iScience, 2023, 26(10):107887] PubMed: 37771660
Acquisition of neural fate by combination of BMP blockade and chromatin modification [ iScience, 2023, 26(10):107887] PubMed: 37771660

RETURN POLICY
Selleck Chemical’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.

SHIPPING AND STORAGE
Selleck products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Selleck Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Selleck products are stable under the recommended conditions.

NOT FOR HUMAN, VETERINARY DIAGNOSTIC OR THERAPEUTIC USE.